AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
[{"orgOrder":0,"company":"PanTheryx","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"TruBiotics\u00ae Grows Its Family: New Baby Drops Feature Clinically Researched Probiotic Strain BB-12\u00ae Shown to Reduce Excessive Infant Crying and Fussing, and Increase Sleep Duration","therapeuticArea":"Gastroenterology","highestDevelopmentStatus":"Approved","country":"U.S.A","productType":"Large molecule","productStatus":"Approved","date":"March 2022","url1":"","url2":"","graph1":"Gastroenterology","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals for Lactobacillus Rhamnosus

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            Kids Chewable probiotic supplements, TruBiotics (Bifidobacterium) and Lactobacillus launched by company, the two most-clinically researched probiotic types to support digestive and immune heath for children.

            Lead Product(s): Bifidobacterium,Lactobacillus Rhamnosus

            Therapeutic Area: Gastroenterology Product Name: TruBiotics

            Highest Development Status: Approved Product Type: Large molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable March 02, 2022

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Post Enquiry
            POST ENQUIRY